Literature DB >> 28076787

IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex.

Khian Hong Pua1, Dylan T Stiles1, Mathew E Sowa2, Gregory L Verdine3.   

Abstract

Natural products have demonstrated utility in the clinic and can also act as probes to understand complex cellular pathways. Sanglifehrin A (SFA) is a mixed polyketide and non-ribosomal peptide synthase natural product with sub-nano-molar affinity for its receptor cyclophilin A (PPIA). It has been shown to behave in vitro as an immune suppressant. Here, we identify inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) as an intracellular target of the PPIA-SFA binary complex. The formation of this ternary complex does not inhibit the enzymatic activity of IMPDH2. Rather, ternary complex formation modulates cell growth through interaction with the cystathionine-β-synthase (CBS) domain of IMPDH2. We further demonstrate that the SFA complex is highly isoform selective for IMPDH2 (versus IMPDH1). This work reveals a role for the CBS domains of IMPDH2 in cellular proliferation, suggesting a more complex role than previously suspected for IMPDH2 in T cell activation and proliferation.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cyclophilin A; cystathionine-β-synthase domains; inosine-5′-monophosphate dehydrogenase; protein-protein interactions; sanglifehrin A

Mesh:

Substances:

Year:  2017        PMID: 28076787     DOI: 10.1016/j.celrep.2016.12.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  13 in total

1.  The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections.

Authors:  Gyan Modi; Gary M Marqus; Mohana Rao Vippila; Deviprasad R Gollapalli; Youngchang Kim; Adhar C Manna; Shibin Chacko; Natalia Maltseva; Xingyou Wang; Ryan T Cullinane; Yubo Zhang; Judy L M Kotler; Petr Kuzmic; Minjia Zhang; Ann P Lawson; Andrzej Joachimiak; Ambrose Cheung; Barry B Snider; David M Rothstein; Gregory D Cuny; Lizbeth Hedstrom
Journal:  ACS Infect Dis       Date:  2021-09-30       Impact factor: 5.578

Review 2.  Unifying principles of bifunctional, proximity-inducing small molecules.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Chem Biol       Date:  2020-03-20       Impact factor: 15.040

3.  Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.

Authors:  Ziyang Zhang; Kevan M Shokat
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-26       Impact factor: 16.823

4.  A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.

Authors:  Rubén M Buey; David Fernández-Justel; Íñigo Marcos-Alcalde; Graeme Winter; Paulino Gómez-Puertas; José María de Pereda; José Luis Revuelta
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

5.  IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.

Authors:  Shiyu Duan; Wenqing Huang; Xiaoting Liu; Xuming Liu; Nana Chen; Qiong Xu; Yukun Hu; Wen Song; Jun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2018-12-05

6.  IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.

Authors:  Gerson Dierley Keppeke; Chia Chun Chang; Min Peng; Li-Yu Chen; Wei-Cheng Lin; Li-Mei Pai; Luis Eduardo Coelho Andrade; Li-Ying Sung; Ji-Long Liu
Journal:  Cell Div       Date:  2018-06-15       Impact factor: 5.130

Review 7.  Emerging small-molecule treatments for multiple sclerosis: focus on B cells.

Authors:  Aaron Gregson; Kaitlyn Thompson; Stella E Tsirka; David L Selwood
Journal:  F1000Res       Date:  2019-03-01

8.  A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

Authors:  David E Gordon; Gwendolyn M Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z Guo; Danielle L Swaney; Tia A Tummino; Ruth Hüttenhain; Robyn M Kaake; Alicia L Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J Polacco; Hannes Braberg; Jacqueline M Fabius; Manon Eckhardt; Margaret Soucheray; Melanie J Bennett; Merve Cakir; Michael J McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T Kirby; James E Melnyk; John S Chorba; Kevin Lou; Shizhong A Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J P Mathy; Tina Perica; Kala B Pilla; Sai J Ganesan; Daniel J Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A Wankowicz; Markus Bohn; Raphael Trenker; Janet M Young; Devin Cavero; Joe Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M White; Lisa Miorin; David Agard; Michael Emerman; Davide Ruggero; Adolfo García-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K Shoichet; Nevan J Krogan
Journal:  bioRxiv       Date:  2020-03-22

9.  Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.

Authors:  Albertus Eka Yudistira Sarwono; Shinya Mitsuhashi; Mohammad Hazzaz Bin Kabir; Kengo Shigetomi; Tadashi Okada; Fumina Ohsaka; Satoko Otsuguro; Katsumi Maenaka; Makoto Igarashi; Kentaro Kato; Makoto Ubukata
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

10.  COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics.

Authors:  Dhanusha Yesudhas; Ambuj Srivastava; M Michael Gromiha
Journal:  Infection       Date:  2020-09-04       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.